These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7344908)

  • 1. Aging as a confounding factor in carcinogenicity bioassays.
    von Wittenau MS; Gans DJ
    Drug Chem Toxicol; 1981; 4(4):307-10. PubMed ID: 7344908
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of transplacental exposure into routine carcinogenicity bioassays.
    Swenberg JA
    Natl Cancer Inst Monogr; 1979 May; (51):265-8. PubMed ID: 481580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The power and interpretation of the carcinogenicity bioassay.
    Clayson DB; Krewski D; Munro IC
    Regul Toxicol Pharmacol; 1983 Dec; 3(4):329-48. PubMed ID: 6658029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
    Guess H; Crump K; Peto R
    Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
    [No Abstract]   [Full Text] [Related]  

  • 7. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implant test. Six tests for carcinogenicity.
    Longstaff E
    Br J Cancer; 1978 Jun; 37(6):954-9. PubMed ID: 678434
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenicity of carteolol hydrochloride in Balb/c mice.
    Kurosumi M; Hatori M; Nishino H
    Farmaco Prat; 1979 May; 34(5):202-9. PubMed ID: 456557
    [No Abstract]   [Full Text] [Related]  

  • 11. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 3. The concept of negativity in experimental carcinogenesis.
    Clayson DB; Krewski D
    Mutat Res; 1986 May; 167(3):233-40. PubMed ID: 3960042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals.
    Griesemer RA; Cueto C
    IARC Sci Publ; 1980; (27):259-81. PubMed ID: 6893701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,6-Dinitropyrene: mutagenicity in Salmonella and carcinogenicity in BALB/c mice.
    Tokiwa H; Otofuji T; Horikawa K; Kitamori S; Otsuka H; Manabe Y; Kinouchi T; Ohnishi Y
    J Natl Cancer Inst; 1984 Dec; 73(6):1359-63. PubMed ID: 6392672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro-In Vivo Carcinogenicity.
    Steinberg P
    Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays.
    Chu KC; Cueto C; Ward JM
    J Toxicol Environ Health; 1981; 8(1-2):251-80. PubMed ID: 7328708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-carcinogenicity in mice of a sulfonic acid derivative of 2-naphthylamine.
    Della Porta G; Dragani TA
    Carcinogenesis; 1982; 3(6):647-9. PubMed ID: 7116558
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassays with inbred mice: their relevance for the random-bred animal.
    Poel WE
    Prog Exp Tumor Res; 1969; 11():444-60. PubMed ID: 4305963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.